Saniona
2.905
SEK
+3.38 %
SANION
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
3 following
+3.38%
-33.06%
-28.89%
+49.43%
-14.38%
-48.99%
-70.04%
-86.67%
-25.82%
saniona.com/investors
Saniona is active in biotechnology. Today, research and development of drugs for the treatment of nerve diseases and other autoimmune diseases are conducted. The drug portfolio is broad and includes drugs that are currently in various clinical phases. Some of the work is also carried out in collaboration with other cooperation partners in the pharmaceutical industry. Saniona is headquartered in Glostrup.
Revenue
16.84M
EBIT %
-481.41 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
SANION
Daily low / high price
2.72 / 2.96
SEK
Market cap
325.03M SEK
Turnover
930.3K SEK
Volume
328K
Latest videos
Financial calendar
Interim report
2024-11-28
Annual report
2025-02-27
Major OwnersSource: Millistream Market Data AB
| Owner | Capital | Votes |
|---|---|---|
| Avanza Pension | 8.5 % | 8.5 % |
| Nordnet Pensionsförsäkring AB | 5.4 % | 5.4 % |
| Nordea Life & Pension | 3.0 % | 3.0 % |
| Tredje AP-Fonden | 2.8 % | 2.8 % |
| Jörgen Drejer | 2.3 % | 2.3 % |
| Joakim Tedroff | 2.2 % | 2.2 % |
| Dan Peters | 2.1 % | 2.1 % |
| Thomas Kreutzfeldt | 1.8 % | 1.8 % |
| Wilhelm Risberg | 1.8 % | 1.8 % |
| Thomas Feldthus | 1.3 % | 1.3 % |
ShowingAll content types
BioStock: Saniona provided a tesofensine update
Update on Tesofensine Application
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools